Advanced Search
Rani Therapeutics

Rani Therapeutics

A company developing biotherapeutics for the delivery of large drug molecules, peptides, proteins and antibodies

All edits by  Jon Kirchman 

Edits on 30 Apr, 2019
Jon Kirchman
Jon Kirchman approved a suggestion from Golden's AI on 30 Apr, 2019
Edits made to:
Article (+13/-13 characters)

On May 26, 2015 Rani Therapeutics completed their series C funding round with $37.5 million in funding from Western Life Sciences Venture Fund, VentureHealthVentureHealth, The Stevanato Group, Pinemount Investment, Pacific Venture Opportunity Fund, Novartis, InCube Ventures, Google Ventures, and Crystal Horizon Investments.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.